Back to CAPTRUST Financial Advisors CAPTRUST Financial Advisors

CORTCORT

Showing 8 of 24 quarters

Position history for CAPTRUST Financial AdvisorsCAPTRUST Financial Advisors's holdings in Corcept Therapeutics Incorporated

Yes. CAPTRUST Financial Advisors holds 37,447 shares of CORT (Corcept Therapeutics), worth $3.3M, as of its Q2 2026 13F filing. It increased the position by 13,652 shares (+57.4%) from Q1 2026. CAPTRUST Financial Advisors has held CORT since Q3 2020, across 24 quarterly 13F filings.

Current Value

$3.3M

Current Shares

37,447

Total Value Change

-$1.5M

Total Shares Change

-66,293

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
37,447
+57.4%
$3.3M0.0%$86.95
38
2026-Q1
Increased
23,795
+152.6%
$959,1760.0%$40.31
40
2025-Q4
Decreased
9,422
-13.2%
$327,8860.0%$34.80
0
2025-Q3
Increased
10,848
+33.4%
$901,5770.0%$83.11
32
2025-Q2
Decreased
8,131
-11.0%
$596,8150.0%$73.40
0
2025-Q1
Decreased
9,132
-92.0%
$1M0.0%$114.22
0
2024-Q4
Increased
113,988
+9.9%
$5.7M0.0%$50.39
30
2024-Q3
Decreased
103,740
-15.7%
$4.8M0.0%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used